Erika A Waters, Caitlin Yuen, Clarissa Gaona Romero, Julia Maki, Bryce Puesta Takenaka, Aantaki Raisa, Erin Linnenbringer, Jada G Hamilton, Jessica Mozersky, George P Souroullas, Chelsey R Carter
{"title":"Hope Tempered by Caution: Public Beliefs in the USA about the Benefits and Drawbacks of Using Epigenetic Technologies in Clinical Care.","authors":"Erika A Waters, Caitlin Yuen, Clarissa Gaona Romero, Julia Maki, Bryce Puesta Takenaka, Aantaki Raisa, Erin Linnenbringer, Jada G Hamilton, Jessica Mozersky, George P Souroullas, Chelsey R Carter","doi":"10.1159/phg/aenag003","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Clinical applications of epigenetic technologies could revolutionize precision medicine. However, successful uptake in clinical settings may be influenced by public opinion. We investigated public beliefs about possible benefits and drawbacks of epigenetic-based medical technologies.</p><p><strong>Methods: </strong>We recruited 153 adults from across the USA to participate in 1 of 27 virtual focus groups, each lasting 45-75 min. Groups were stratified by education (less than bachelor's degree vs. bachelor's degree or more) and race and ethnicity (black or African American, Asian, Indigenous [Native Hawaiian, Pacific Islander, American Indian, Alaska Native], Hispanic, and white). Participants viewed an educational video about epigenetics prior to discussion. We used inductive and deductive qualitative content analysis.</p><p><strong>Results: </strong>Participants indicated that epigenetic technologies could be used to guide risk-stratified prevention (i.e., engage in behaviors to reduce the risk of developing a health condition; engage in screening and early-detection behaviors to enable early treatment; facilitate clinical history-taking; inform reproductive planning decisions) and to develop novel therapeutics and editing approaches (i.e., new medications; epigenetic editing). However, participants also mentioned concerns about the ethical, legal, and social implications (ELSIs) of epigenetics, including exacerbating health disparities; the high cost of treatment and health insurance; promoting eugenics; and epigenetic-based discrimination by healthcare providers. Each of the race, education, and ethnicity strata included content related to each of the three major subthemes of risk-stratified prevention, novel therapeutics, and ELSI considerations.</p><p><strong>Conclusion: </strong>Efforts to translate basic epigenetics research to clinical practice hold promise, but it is also critical to create solutions that address people's concerns.</p>","PeriodicalId":49650,"journal":{"name":"Public Health Genomics","volume":" ","pages":"278-288"},"PeriodicalIF":2.2000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13688360/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Public Health Genomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/phg/aenag003","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/5 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Clinical applications of epigenetic technologies could revolutionize precision medicine. However, successful uptake in clinical settings may be influenced by public opinion. We investigated public beliefs about possible benefits and drawbacks of epigenetic-based medical technologies.
Methods: We recruited 153 adults from across the USA to participate in 1 of 27 virtual focus groups, each lasting 45-75 min. Groups were stratified by education (less than bachelor's degree vs. bachelor's degree or more) and race and ethnicity (black or African American, Asian, Indigenous [Native Hawaiian, Pacific Islander, American Indian, Alaska Native], Hispanic, and white). Participants viewed an educational video about epigenetics prior to discussion. We used inductive and deductive qualitative content analysis.
Results: Participants indicated that epigenetic technologies could be used to guide risk-stratified prevention (i.e., engage in behaviors to reduce the risk of developing a health condition; engage in screening and early-detection behaviors to enable early treatment; facilitate clinical history-taking; inform reproductive planning decisions) and to develop novel therapeutics and editing approaches (i.e., new medications; epigenetic editing). However, participants also mentioned concerns about the ethical, legal, and social implications (ELSIs) of epigenetics, including exacerbating health disparities; the high cost of treatment and health insurance; promoting eugenics; and epigenetic-based discrimination by healthcare providers. Each of the race, education, and ethnicity strata included content related to each of the three major subthemes of risk-stratified prevention, novel therapeutics, and ELSI considerations.
Conclusion: Efforts to translate basic epigenetics research to clinical practice hold promise, but it is also critical to create solutions that address people's concerns.
期刊介绍:
''Public Health Genomics'' is the leading international journal focusing on the timely translation of genome-based knowledge and technologies into public health, health policies, and healthcare as a whole. This peer-reviewed journal is a bimonthly forum featuring original papers, reviews, short communications, and policy statements. It is supplemented by topic-specific issues providing a comprehensive, holistic and ''all-inclusive'' picture of the chosen subject. Multidisciplinary in scope, it combines theoretical and empirical work from a range of disciplines, notably public health, molecular and medical sciences, the humanities and social sciences. In so doing, it also takes into account rapid scientific advances from fields such as systems biology, microbiomics, epigenomics or information and communication technologies as well as the hight potential of ''big data'' for public health.